How to use the speech recognition tool?

NCT01490827

Argus II retinal prosthesis system post-market surveillance study protocol

Argus II retinal prosthesis system post-market surveillance study protocol (Argus II PM-01-01).

Type: Interventional



Status of the trial: Completed

Orphan Drug Recognition: No

Inclusion

  • Opening Date: 2013-12-19
  • Closing Date: 2019-09-04

Criteria

Inclusion: adults, age 25 or older, with severe to profound outer retinal degeneration causative of blindness

Exclusion: ocular diseases or conditions that could prevent Argus II from working (e.g. optic nerve disease, history of retinal detachment, trauma, severe strabismus, etc.)

More information

Children: No

Adults: Yes

Funder Type: public

HCP: Other investigators


Within ERN-EYE members

Principal investigators




Other investigators

Workgroups

  • Retinal Rare Eye Diseases (WG1)

Subscribe to our mailing list

* indicates required

This ERN is supported by: